Cefazolin
Cefazolin for Injection, USP
Approved
Approval ID
47a8928f-708d-418a-829b-36eded96bac0
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jun 17, 2020
Manufacturers
FDA
Fresenius Kabi USA, LLC
DUNS: 608775388
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cefazolin Sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code63323-449
Application NumberANDA065306
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefazolin Sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJune 17, 2020
FDA Product Classification
INGREDIENTS (1)
CEFAZOLIN SODIUMActive
Quantity: 20 g in 100 mL
Code: P380M0454Z
Classification: ACTIM
Cefazolin Sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code63323-238
Application NumberANDA065306
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefazolin Sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJune 17, 2020
FDA Product Classification
INGREDIENTS (1)
CEFAZOLIN SODIUMActive
Quantity: 10 g in 1 1
Code: P380M0454Z
Classification: ACTIM